Structure-Conduct-Performance (SCP)
for Research and experimental development on natural sciences and engineering (ISIC 7210)
The Research and experimental development on natural sciences and engineering industry is highly susceptible to structural influences. Factors like government funding policies (RP09), intellectual property regimes (ER07, RP12), global value chain architecture (ER02), and talent availability (MD07,...
Why This Strategy Applies
An economic framework that links Industry Structure to Firm Conduct and Market Performance. Provides academic context for industry analysis.
GTIAS pillars this strategy draws on — and this industry's average score per pillar
These pillar scores reflect Research and experimental development on natural sciences and engineering's structural characteristics. Higher scores indicate greater complexity or risk — see the full scorecard for all 81 attributes.
Market structure, firm behaviour, and economic outcomes
Market Structure
Driven by high capital intensity (ER03) and significant structural knowledge asymmetry (ER07) that creates a 'moat' around specialized intellectual property.
Highly concentrated at the top-tier (Major research universities and defense-industrial incumbents) with a long tail of boutique R&D firms.
High; output is intrinsically non-fungible, characterized by proprietary research trajectories and IP-protected technical solutions rather than commodity services.
Firm Conduct
Cost-plus or grant-indexed pricing; firms are generally price-makers within niche domains but face high dependency on external fiscal architectures (RP09).
Primary focus is on high-stakes R&D races to secure sovereign strategic criticality (RP02) and maintain competitive advantage in emerging technology cycles.
Low; competitive success is driven by reputation, citation metrics, and track records in securing government funding rather than mass-market advertising.
Market Performance
Variable; high potential for 'winner-take-most' returns on successful patent commercialization, yet overall margins are pressured by long-duration liquidity risks (LI05).
Significant friction in translational research (the 'valley of death') caused by structural procedural friction (RP05) and regulatory density (RP01).
High positive externality generation; the industry serves as the primary engine for technological advancement, despite systemic risks regarding IP erosion (RP12).
Increasing geopolitical coupling (RP10) is driving a shift from open-science collaboration models toward fragmented, national-security-oriented R&D clusters.
Diversify funding streams away from pure-play subsidy dependency to ensure operational agility against fiscal volatility.
Strategic Overview
The Structure-Conduct-Performance (SCP) framework provides a robust lens through which to analyze the Research and experimental development on natural sciences and engineering industry (ISIC 7210). This industry's unique characteristics, such as long development cycles, high capital intensity (ER03), and significant reliance on public and private funding (RP09, MD03), create a distinct market structure. This structure, in turn, dictates the conduct of research institutions, private R&D firms, and individual scientists, influencing their collaboration strategies, intellectual property management, and commercialization pathways.
Understanding the interplay between market structure, firm conduct, and ultimate performance outcomes is critical for strategic decision-making. For instance, the concentration of funding (MD07) or the stringency of IP protection (ER07, RP12) directly impacts how research organizations operate and compete. By applying the SCP framework, stakeholders can identify barriers to entry, assess the competitive intensity of various research domains, and formulate strategies to enhance innovation, drive commercialization, and ensure long-term sustainability and impact in a rapidly evolving scientific and technological landscape.
4 strategic insights for this industry
Funding Concentration & Competitive Conduct
The structural competitive regime (MD07) and fiscal architecture (RP09) often lead to a concentration of funding among a few large institutions or established players. This structure influences conduct by encouraging collaboration among smaller entities to secure grants or driving larger entities to acquire promising startups, impacting overall market performance in terms of innovation diversity and accessibility to resources for new entrants.
IP Landscape & Commercialization Pathways
The high structural knowledge asymmetry (ER07) and structural IP erosion risk (RP12) dictate how research is commercialized. Conduct often involves complex patenting strategies, licensing agreements, or spin-off creation, which are direct responses to the legal and competitive structure. Market performance is measured by successful technology transfer rates, royalty income, and the formation of new tech ventures, all heavily influenced by the IP structure.
Geopolitical Structure & Research Collaboration
The global value-chain architecture (ER02) and geopolitical coupling (RP10) significantly influence the structure of international research collaborations. Conduct involves navigating diverse regulatory landscapes (RP01, RP05), managing data sovereignty (RP03), and mitigating sanctions contagion (RP11). This impacts the performance of global scientific endeavors, determining access to talent, resources, and shared scientific advancement, as well as the 'brain drain' risk (ER07).
Talent Mobility & Institutional Performance
The structural competitive regime (MD07) and demographic dependency (CS08) create a 'talent war' in specialized scientific and engineering fields. Institutions' conduct focuses on recruitment, retention, and training strategies. The performance is directly linked to the ability to attract and maintain a high-quality workforce, which is critical for innovation output and maintaining relevance (MD01) in an environment of high investment risk.
Prioritized actions for this industry
Diversify Funding Portfolios to Mitigate Fiscal Volatility
Given the high vulnerability to fiscal policy shifts (RP09) and funding volatility (MD03), organizations should proactively seek funding from multiple sources, including government grants, corporate partnerships, philanthropic organizations, and venture capital, to stabilize operations and reduce dependency on any single channel.
Optimize Intellectual Property Strategy for Global Markets
With significant IP erosion risk (RP12) and knowledge asymmetry (ER07), a robust and globally-aware IP strategy is essential. This includes strategic patenting, cross-border licensing, and active defense against infringement, particularly in regions with weak IP enforcement or where geopolitical factors (RP10) complicate protection.
Foster Strategic International Collaborations and Talent Pipelines
To leverage global value-chain architecture (ER02) and mitigate talent shortages (CS08), proactively establish international research partnerships. This includes joint ventures, shared facilities, and talent exchange programs, carefully navigating geopolitical friction (RP10) and compliance rigidities (RP05).
Develop Agile Commercialization Models
In response to slow commercialization pipelines (MD06) and the long-term ROI challenge (ER01), adopt more agile approaches to technology transfer and product development. This could involve closer industry engagement from early research stages, establishing incubators/accelerators, or using lean startup methodologies for scientific spin-offs.
From quick wins to long-term transformation
- Conduct an internal IP audit and review current protection strategies.
- Identify 2-3 new non-traditional funding sources to approach.
- Map current international collaborations and identify potential expansion areas.
- Establish dedicated teams or partnerships for commercialization and technology transfer.
- Implement a 'funding diversification' quota for new research initiatives.
- Develop formal agreements for international data sharing and talent mobility compliant with RP03 and RP05.
- Actively participate in policy advocacy to shape favorable IP and R&D funding landscapes.
- Build a reputation as a global hub for specific research areas, attracting diverse funding and talent.
- Invest in internal capabilities for market analysis and commercial viability assessment for early-stage research.
- Over-reliance on existing funding channels without exploring alternatives, leading to vulnerability.
- Insufficient investment in IP protection or reactive rather than proactive IP management.
- Ignoring geopolitical tensions that could disrupt international collaborations or supply chains.
- Failing to adapt commercialization strategies to the unique demands of scientific breakthroughs.
Measuring strategic progress
| Metric | Description | Target Benchmark |
|---|---|---|
| Funding Diversification Index | Measures the proportion of funding derived from different sources (e.g., government, corporate, philanthropic). | Achieve 4+ distinct significant funding channels, with no single source exceeding 40% of total R&D budget. |
| Patent Application & Grant Rate | Number of patents filed and granted annually, indicating IP generation and protection effectiveness. | Increase patent grants by 10% year-over-year, with a focus on commercially viable innovations. |
| International Research Collaboration Index | Number and impact of active international research partnerships, weighted by global scientific impact. | Expand active collaborations with top-tier international institutions by 15% within 3 years. |
| Commercialization Success Rate | Percentage of research projects that result in successful licensing, spin-off creation, or product launch within a defined timeframe. | Achieve a 20% commercialization success rate for eligible projects within 5 years of completion. |
Software to support this strategy
These tools are recommended across the strategic actions above. Each has been matched based on the attributes and challenges relevant to Research and experimental development on natural sciences and engineering.
Capsule CRM
10,000+ customers worldwide • Includes Transpond marketing platform
Transpond's email marketing and audience tools support proactive brand communication that builds customer loyalty and reduces churn-driven reputational fragility
Cost-effective CRM for growing teams — manage contacts, track deals and pipeline, build customer relationships, and streamline day-to-day work. Paired with Transpond, a dedicated marketing platform for email campaigns and audience management.
Try Capsule FreeAffiliate link — we may earn a commission at no cost to you.
HubSpot
Free forever plan • 288,700+ customers in 135+ countries
Deal intelligence, win/loss analytics, and pipeline data give sales teams the evidence to defend price with ROI proof rather than discounting reactively against commodity competition
All-in-one CRM and go-to-market platform used by 288,700+ businesses across 135+ countries. Connects marketing, sales, service, content, and operations in one system — free forever plan to start, paid tiers to scale.
Try HubSpot FreeAffiliate link — we may earn a commission at no cost to you.
Bitdefender
Free trial available • 500M+ users protected • Gartner Customers' Choice 2025
Threat detection and device-level controls prevent unauthorised access to institutional knowledge, proprietary data, and sensitive IP held on employee machines
Enterprise-grade endpoint protection simplified for small and medium businesses. Multi-layered defence against ransomware, phishing, and fileless attacks — with centralised management across all devices. Gartner Customers' Choice 2025; AV-TEST Best Protection 2025.
Try Bitdefender FreeAffiliate link — we may earn a commission at no cost to you.